StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1119
This month
18
This week
4
This year
109
Today
1
Yesterday
3
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
4
2023 - 10 - 30
4
2023 - 10 - 04
5
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 26
5
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
4
2023 - 02 - 13
5
2023 - 02 - 08
4
2023 - 01 - 16
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
5
2022 - 05 - 27
5
2022 - 04 - 26
4
2022 - 03 - 25
5
2022 - 03 - 22
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2021 - 12 - 22
3
2021 - 12 - 20
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 10 - 08
3
2021 - 10 - 01
3
2021 - 08 - 25
4
2021 - 08 - 24
3
2021 - 08 - 19
4
2021 - 08 - 06
3
2021 - 08 - 05
5
2021 - 06 - 25
3
2021 - 06 - 04
3
2021 - 06 - 02
3
2021 - 05 - 10
3
2021 - 04 - 13
3
2021 - 04 - 09
3
2021 - 04 - 07
3
2021 - 03 - 30
3
2021 - 03 - 18
3
Sector
Commercial services
10
Communications
7
Consumer durables
5
Consumer non-durables
15
Consumer services
2
Distribution services
4
Electronic technology
19
Finance
4
Health care and social assistance
1
Health services
14
Health technology
1119
Industrial services
1
Information
4
Manufacturing
136
Mining, quarrying, and oil and gas extraction
2
N/a
65
Non-energy minerals
1
Process industries
16
Producer manufacturing
20
Professional, scientific, and technical services
18
Retail trade
2
Technology services
17
Tags
America
67
Antibody
13
Application
12
Approval
21
Biosimilar
39
Breast
13
Cancer
106
Covid
17
Covid-19
12
Device
14
Diabetes
18
Diagnostics
19
Disease
76
Drug
116
Drug delivery
11
Earnings
21
Europe
17
Expansion
12
Expected
35
Eye
21
Fda
29
Financial
24
Financial results
13
Gene therapy
11
Global
229
Growing
47
Growth
263
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
20
Market
600
N/a
1119
Novartis
136
Patent
13
People
20
Pharma
17
Pharmaceuticals
17
Pipeline
12
Positive
20
Potential
13
Reach
34
Report
195
Research
129
Respiratory
15
Results
52
Risk
11
Sales
12
Sclerosis
13
Set
17
Study
17
T-cell
12
Technology
14
Therapeutics
115
Therapy
90
Treatment
138
Trial
25
Vaccine
16
Year
12
Entities
3m company
12
Abbott laboratories
119
Abbvie inc.
239
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
13
Alcon inc.
15
Alkermes plc
10
Amgen inc.
195
Aptargroup, inc.
6
Astellas pharma inc
70
Astrazeneca plc
198
Autolus therapeutics plc
7
Bausch health companies inc.
74
Baxter international inc.
43
Becton, dickinson and company
18
Biogen inc.
53
Biontech se
10
Bluebird bio, inc.
8
Boston scientific corporation
16
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
100
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
11
Eli lilly and company
135
Endo international plc
19
General electric company
8
Genmab a/s
21
Gilead sciences, inc.
28
Glaxosmithkline plc
305
Grifols sa
10
Ionis pharmaceuticals, inc.
8
Jazz pharmaceuticals plc
14
Johnson & johnson
232
Koninklijke philips n.v.
19
Mallinckrodt plc
17
Medtronic plc
36
Novartis ag
1119
Novo nordisk a/s
28
Orange
7
Orchard therapeutics plc
9
Perrigo company
8
Pfizer, inc.
85
Qiagen n.v.
7
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
8
Sanofi
326
Sarepta therapeutics, inc.
7
Smith & nephew plc
7
Stryker corporation
11
Takeda pharmaceutical company limited
50
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
205
Thermo fisher scientific inc
51
Ucb s.a.
8
Uniqure n.v.
9
Vericel corporation
8
Viatris inc.
119
Symbols
AAPL
1195
ABB
1433
ABBV
789
ABLZF
1172
ABT
1571
ACN
602
AMGN
571
ARVL
4200
AVGO
594
BDX
690
BNPQF
1740
BNPQY
1740
CSCO
899
DELL
579
DHR
726
DOW
555
ERIC
1604
EXTR
581
F
638
FNCTF
6889
FRBA
601
GE
889
GLAXF
619
GOOG
1073
GOOGL
1073
GSK
792
HON
1792
HUBS
1400
IBM
654
INTC
947
IT
594
JNJ
2895
LLY
1122
LMT
576
LTUM
973
LYV
717
MDT
1148
MMM
926
MS
3868
MSFT
1197
MT
591
NOC
589
NOK
917
NOKBF
993
NVS
1119
NVSEF
949
ORCL
1158
PCRFF
651
PCRFY
651
PHG
957
PPRUF
1065
PPRUY
1066
SAP
1480
SAPGF
1235
SNOW
796
SNY
2821
SNYNF
2238
TMO
1415
VZ
1214
XYF
656
Exchanges
Amex
4
Nasdaq
1055
Nyse
1119
Crawled Date
2024 - 02 - 14
4
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
4
2023 - 10 - 30
4
2023 - 10 - 04
5
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
4
2023 - 02 - 14
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
5
2022 - 05 - 27
5
2022 - 04 - 26
4
2022 - 03 - 25
5
2022 - 03 - 22
4
2022 - 03 - 14
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 10 - 08
3
2021 - 10 - 01
3
2021 - 09 - 01
4
2021 - 08 - 25
4
2021 - 08 - 24
3
2021 - 08 - 19
4
2021 - 08 - 06
3
2021 - 08 - 05
5
2021 - 06 - 25
3
2021 - 06 - 04
3
2021 - 06 - 02
3
2021 - 05 - 10
3
2021 - 04 - 13
3
2021 - 04 - 09
3
2021 - 04 - 07
3
2021 - 03 - 30
3
2021 - 03 - 18
3
Crawled Time
00:00
43
00:20
10
01:00
43
01:08
1
02:00
25
03:00
34
04:00
23
04:20
8
05:00
25
06:00
69
06:03
2
07:00
39
08:00
32
08:20
4
08:23
1
09:00
44
10:00
30
11:00
46
11:01
1
12:00
61
12:15
5
12:20
12
12:30
6
13:00
18
13:14
1
13:15
6
13:20
6
13:30
3
13:58
1
14:00
36
14:15
2
14:20
10
14:30
7
14:49
1
15:00
48
15:15
4
15:20
15
15:30
14
16:00
49
16:01
1
16:20
4
17:00
61
18:00
52
19:00
43
20:00
44
20:20
3
21:00
34
22:00
51
22:01
1
23:00
39
23:09
1
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
spacfeed.com
1
www.globenewswire.com
229
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
881
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
N::A
symbols :
NVS
save search
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Published:
2024-04-24
(Crawled : 05:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.0%
|
O:
-0.49%
H:
0.0%
C:
0.0%
malaria
positive
treatment
for
novartis
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published:
2024-04-23
(Crawled : 18:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.32%
|
O:
4.32%
H:
0.0%
C:
0.0%
lutathera
fda
first
approved
tumors
for
novartis
therapy
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
Published:
2024-04-23
(Crawled : 05:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.32%
|
O:
4.32%
H:
0.0%
C:
0.0%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
0.39%
|
O:
0.39%
H:
0.0%
C:
0.0%
sales
expansion
novartis
growth
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-04-22
(Crawled : 22:00)
- prnewswire.com
RBGPF
|
News
|
$52.06
6.46%
4.8K
|
Consumer Non-Durables
|
0.08%
|
O:
0.98%
H:
5.46%
C:
-0.89%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-3.74%
|
O:
-3.15%
H:
0.0%
C:
-0.61%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
1.13%
|
O:
0.96%
H:
2.38%
C:
0.17%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
RBGLY
|
News
|
$10.59
-2.05%
850K
|
Manufacturing
|
1.7%
|
O:
-0.28%
H:
2.18%
C:
1.99%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.32%
|
O:
4.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
1.6%
|
O:
0.17%
H:
1.48%
C:
1.43%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
0.49%
|
O:
0.56%
H:
0.41%
C:
-0.07%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.7%
|
O:
1.7%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
1.03%
|
O:
0.4%
H:
0.0%
C:
0.0%
drug
astrazeneca
set
key
therapeutics
market
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
1.46%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
6.51%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-10.9%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
6.51%
|
O:
0.87%
H:
0.16%
C:
-0.59%
kesimpta
sclerosis
novartis
show
benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
0.35%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
News
|
$20.97
-0.19%
0.0%
650K
|
Health Technology
|
1.64%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
1.83%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.21
-2.44%
-2.5%
320K
|
Health Technology
|
-1.33%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
-0.84%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
News
|
$4.645
-7.1%
-7.64%
3.9M
|
Health Technology
|
-35.4%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
1.38%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
3.21%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
1.83%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
2.45%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
4.87%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
0.41%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
|
0.6%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
3.08%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
3.02%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.54%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
-5.9%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
2.02%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.54%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
0.25%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-11.83%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.01%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.31%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-9.36%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.07%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
-4.03%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.33%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.99%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$108.38
-1.18%
-1.19%
400K
|
Health Technology
|
-5.16%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
1.68%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
5.31%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.73%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.2%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-4.54%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-18.06%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
0.96%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
0.29%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
5.04%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published:
2024-04-06
(Crawled : 20:20)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
leqvio
novartis
therapy
show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published:
2024-04-03
(Crawled : 06:00)
- prnewswire.com
CAJPY
|
$28.73
-0.41%
39K
|
n/a
|
-2.91%
|
O:
-0.3%
H:
0.54%
C:
0.54%
CAJFF
|
$29.0664
-28.15%
760
|
Electronic Technology
|
-2.61%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
1.05%
|
O:
-2.86%
H:
0.17%
C:
0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.71%
|
O:
0.04%
H:
0.46%
C:
-0.08%
PHG
|
News
|
$20.97
-0.19%
0.0%
650K
|
Health Technology
|
5.47%
|
O:
1.0%
H:
0.0%
C:
0.0%
worldwide
set
market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$21.8
1.63%
1.61%
120K
|
n/a
|
-4.26%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.57%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.57%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$14.705
-2.03%
-2.07%
4.7K
|
Health Technology
|
39.3%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.47
-0.32%
-0.32%
460K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$290.34
3.83%
340
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
55
56
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.